Found 7 matching trials
Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age
PHASE3Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy childre...
Location
320, Novartis Investigational Site
A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications
PHASE3The study is designed to evaluate the safety of TIVc or TIV vaccine in chil...
Location
Novartis Investigational Site 022
Flucelvax (TIVc or QIVc) Pregnancy Registry
N/AThe study is a population based prospective cohort study designed to collec...
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above
PHASE3The present study is designed to confirm the safety and immunogenicity of c...
Location
Rostock University, Department of Tropical Medicine and Infectious Diseases
Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects
PHASE3The purpose of this study is to evaluate the immunologic equivalence of thr...
Location
Anaheim Clincial Trials
Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old
PHASE1To evaluate the safety and immunogenicity of four influenza vaccines in chi...
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above
PHASE3The purpose of this study is to evaluate the safety of a single intramuscul...
Location
Bernhard Nocht Institute